Free tool
FAERS Monitor: Esomeprazole Magnesium
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214278 or its brand name (Esomeprazole Magnesium, Esomeprazole Magnesium). Reports on generic versions are filed under their own applications.
Reports
62,630
Serious
55,187
88% of reports
Hospitalization
28,204
Death reported
6,327
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- chronic kidney disease5,036
- acute kidney injury4,745
- nausea4,386
- diarrhoea4,167
- headache3,799
- fatigue3,798
- drug ineffective3,635
- off label use3,621
- dyspnoea3,491
- pain2,945
- vomiting2,920
- arthralgia2,767
- pyrexia2,672
- malaise2,642
- dizziness2,294
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 415 |
| 2005 | 501 |
| 2006 | 349 |
| 2007 | 528 |
| 2008 | 958 |
| 2009 | 768 |
| 2010 | 849 |
| 2011 | 727 |
| 2012 | 798 |
| 2013 | 992 |
| 2014 | 1,148 |
| 2015 | 1,661 |
| 2016 | 2,297 |
| 2017 | 2,675 |
| 2018 | 5,567 |
| 2019 | 7,259 |
| 2020 | 5,076 |
| 2021 | 4,578 |
| 2022 | 5,194 |
| 2023 | 5,435 |
| 2024 | 5,621 |
| 2025 | 5,372 |
| 2026 | 3,861 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,529 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chronic kidney diseaseSignal | 5,036 | 23.8 | 23.1 | 102,904 |
| acute kidney injurySignal | 4,745 | 10.7 | 10.4 | 40,782 |
| pyrexiaSignal | 2,672 | 2.6 | 2.5 | 2,666 |
| arthralgiaSignal | 2,767 | 2.2 | 2.2 | 1,931 |
| diarrhoeaSignal | 4,167 | 2.2 | 2.1 | 2,712 |
| vomitingSignal | 2,920 | 2.1 | 2.0 | 1,692 |
| dyspnoeaSignal | 3,491 | 2.1 | 2.0 | 1,992 |
| headacheSignal | 3,799 | 2.0 | 2.0 | 2,066 |
| malaiseSignal | 2,642 | 2.0 | 2.0 | 1,399 |
| nausea | 4,386 | 1.9 | 1.8 | 1,820 |
| fatigue | 3,798 | 1.6 | 1.6 | 983 |
| pain | 2,945 | 1.6 | 1.6 | 703 |
| dizziness | 2,294 | 1.5 | 1.5 | 452 |
| off label use | 3,621 | 1.4 | 1.3 | 412 |
| drug ineffective | 3,635 | 0.9 | 0.9 | 23 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.